Citrulline Blood Flow Randomized Trial: What the Evidence Says
Citrulline Blood Flow Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Quick Answer
Citrulline Blood Flow Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public health sources, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 research article.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Citrulline Blood Flow Randomized Trial: What the Evidence Says
Quick Answer
Citrulline Blood Flow Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Acute effect of citrulline malate on flow-mediated dilation and serum pharmacodynamics in healthy young males | research article | 4 | 2026-03-06 | 10.3389/fphys.2026.1773582 |
What The Sources Report
- Gonzalez and Trexler, 2020 Gonzalez et al., 2023 Gonzalez et al., 2023 Figueroa et al., 2020 Gonzalez and Trexler, 2020 Gonzalez et al., 2023 Gough et al., 2021 L-citrulline is a non-essential and non-proteogenic amino acid found primarily in watermelon that functions as a precursor of L-arginine. [Grannes Johan (2026); evidence level 4]
- Malate, an intermediate in the citric acid cycle, is thought to potentially enhance ATP production, though this has not been substantiated by experimental evidence. [Grannes Johan (2026); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
For citrulline blood flow randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Grannes Johan (2026). Acute effect of citrulline malate on flow-mediated dilation and serum pharmacodynamics in healthy young males. DOI: 10.3389/fphys.2026.1773582. PMCID: PMC13002379. PMID: 41867246. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13002379/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed June 10, 2026 by Migaku Evidence Review